Advanced Search
Your search returned 407 results
  • May 21, 2013
    Q4 Revenue of $4.5 Billion Grew 5% at Constant Currency; 4% as Reported

    MINNEAPOLIS - May 21, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2013, which ended April 26, 2013. The Company reported worldwide...

  • Apr 29, 2013
    FDA's Early Feasibility Pilot Program for New Medical Devices Encourages Clinical Studies of Innovative Technology to Occur First in U.S.

    MINNEAPOLIS -- April 29, 2013 -- Vascular specialists at Carolinas HealthCare System in Charlotte, N.C., and the Cleveland Clinic in Ohio recently performed the initial implants of a novel stent...

  • Apr 24, 2013

    MINNEAPOLIS - April 24, 2013 - Medtronic, Inc. (NYSE: MDT) today announced that its Board of Directors unanimously elected Scott C. Donnelly, chairman and CEO of Textron, Inc., a multi-industry...

  • Apr 2, 2013
    New System Designed for Patient Safety, Ease of Use During Open-Heart Procedures

    MINNEAPOLIS - April 2, 2013 - Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the first U.S. clinical uses of its new Affinity Fusion®...

  • Feb 19, 2013
    Revenue of $4.0 Billion Grew 4% on a Constant Currency Basis; 3% as Reported

    MINNEAPOLIS - February 19, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2013, which ended January 25, 2013. The Company reported...

Show 5102550100 per page